NCT07649720

Brief Summary

Participants included in this study will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm weather the capsule is still in the body.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Jun 2026Mar 2027

First Submitted

Initial submission to the registry

May 24, 2026

Completed
22 days until next milestone

Study Start

First participant enrolled

June 15, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2027

Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

6 months

First QC Date

May 24, 2026

Last Update Submit

June 10, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Safety of patency capsule

    The number of patients successfully passing the Patency Capsule within 30 hours compared to the number of patients where the Patency Capsule dissolves in patients with strictures.

    30 hours

  • Efficacy of patency capsule

    The percentage of patients that successfully pass the Patency capsule within 30 hours.

    30 hours

Study Arms (1)

Single arm patency capsule evaluation

EXPERIMENTAL

Participants will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm whether the capsule is still in the body.

Device: NaviCam Patency Capsule

Interventions

The NaviCam Patency Capsule is an accessory to the NaviCam capsule and is intended to verify adequate patency of the gastrointestinal tract prior to administration of the NaviCam capsule in patients with known or suspected strictures.

Single arm patency capsule evaluation

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with suspected or known intestinal stricture (with medical history records, physical examination records, and imaging evidence within the last 6 months.
  • Patients suffering from Crohn's Disease
  • Patients with long-term use of non-steroidal anti-inflammatory drugs.
  • Patients with abdominal symptoms related to intestinal stricture.
  • Patients with chronic inflammatory diseases.
  • Patients with difficulty with balloon-assisted endoscopy (BAE).
  • Patients with a history of small bowel obstruction.
  • Patients with a history of intestinal resection surgery.

You may not qualify if:

  • Patients with esophageal obstruction or swallowing disorder diseases.
  • Patients who are ineligible for surgery or refuse to undergo any abdominal surgery.
  • Patients with known allergies or other contraindications or intolerance to the medications used in this study.
  • Patients with pacemakers or other implanted electronic devices such as cochlear implants, magnetic metal drug infusion pumps, neurostimulators.
  • Pregnant women
  • Patients currently enrolled in another drug or device clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Digestive Health Services

Downers Grove, Illinois, 60515, United States

Location

Related Publications (6)

  • Takeda K, Tashimo H, Miyakawa K, Shimada M, Ohshima N, Tamura A, Nagai H, Matsui H. Patency Capsule Aspiration. Intern Med. 2020 Apr 15;59(8):1071-1073. doi: 10.2169/internalmedicine.4012-19. Epub 2020 Jan 9.

    PMID: 31915319BACKGROUND
  • Okoli A, Ammannagari N, Mazumder M, Nakkala K. When the dissolvable does not dissolve: an agile patency capsule mystery. Am J Gastroenterol. 2014 Apr;109(4):605-7. doi: 10.1038/ajg.2013.435. No abstract available.

    PMID: 24698874BACKGROUND
  • Mitselos IV, Katsanos K, Tsianos EV, Eliakim R, Christodoulou D. Clinical Use of Patency Capsule: A Comprehensive Review of the Literature. Inflamm Bowel Dis. 2018 Oct 12;24(11):2339-2347. doi: 10.1093/ibd/izy152.

    PMID: 29718225BACKGROUND
  • Spada C, Shah SK, Riccioni ME, Spera G, Marchese M, Iacopini F, Familiari P, Costamagna G. Video capsule endoscopy in patients with known or suspected small bowel stricture previously tested with the dissolving patency capsule. J Clin Gastroenterol. 2007 Jul;41(6):576-82. doi: 10.1097/01.mcg.0000225633.14663.64.

    PMID: 17577114BACKGROUND
  • Herrerias JM, Leighton JA, Costamagna G, Infantolino A, Eliakim R, Fischer D, Rubin DT, Manten HD, Scapa E, Morgan DR, Bergwerk AJ, Koslowsky B, Adler SN. Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy. Gastrointest Endosc. 2008 May;67(6):902-9. doi: 10.1016/j.gie.2007.10.063. Epub 2008 Mar 19.

    PMID: 18355824BACKGROUND
  • Kopylov U, Nemeth A, Cebrian A, Wurm Johansson G, Thorlacius H, Fernandez-Urien Sainz I, Koulaouzidis A, Eliakim R, Toth E. Symptomatic retention of the patency capsule: a multicenter real life case series. Endosc Int Open. 2016 Sep;4(9):E964-9. doi: 10.1055/s-0042-112588. Epub 2016 Aug 8.

    PMID: 27652302BACKGROUND

MeSH Terms

Conditions

Crohn DiseaseAbdominal Pain

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Digestive

Study Officials

  • Rockford G Yapp, MD

    Digestive Health Services

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Model Details: Participants in this study will first swallow a patency capsule and then undergo an abdominal X-ray within 30 hours after swallowing the patency capsule to confirm if the capsule is still in the body. The goal of the patency capsule is to screen for strictures that may interfere with the passage of an endoscopy capsule at a later time.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2026

First Posted

June 16, 2026

Study Start

June 15, 2026

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

March 15, 2027

Last Updated

June 16, 2026

Record last verified: 2026-06

Locations